Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Allogene Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 158
- −11 vs. Q1 2025
- Shares held
- 183.6M
- −13.5M (−6.8%) vs. Q1 2025
- Total value
- $207.9M
- −$80.5M (−27.9%) vs. Q1 2025
- New holders
- 16
- 53 more added
- Sold out
- 27
- 45 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 209 | $652.0M |
| Q1 2026 | 209 | $444.7M |
| Q4 2025 | 172 | $222.7M |
| Q3 2025 | 170 | $201.0M |
| Q2 2025 | 158 | $207.9M |
| Q1 2025 | 171 | $288.5M |
| Q4 2024 | 174 | $401.9M |
| Q3 2024 | 156 | $460.4M |
| Q2 2024 | 175 | $385.1M |
| Q1 2024 | 161 | $586.0M |
| Q4 2023 | 170 | $392.4M |
| Q3 2023 | 155 | $413.3M |
| Q2 2023 | 171 | $662.9M |
| Q1 2023 | 176 | $582.3M |
| Q4 2022 | 168 | $700.9M |
| Q3 2022 | 192 | $1.15B |
| Q2 2022 | 161 | $1.15B |
| Q1 2022 | 180 | $836.7M |
| Q4 2021 | 177 | $1.28B |
| Q3 2021 | 169 | $2.26B |
| Q2 2021 | 182 | $2.25B |
| Q1 2021 | 169 | $3.12B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Allogene Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LPL Financial LLC | 173,963 | $196.6K | 0.00% | +2,250+1.3% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 179,576 | $202.9K | 0.00% | −106,457−37.2% | Reduced |
| Ieq Capital, LLC | 186,178 | $210.4K | 0.00% | +120,000+181.3% | Added |
| Rhumbline Advisers | 209,336 | $236.5K | 0.00% | +25,628+14.0% | Added |
| Coastal Bridge Advisors, LLC | 221,059 | $249.8K | 0.02% | 00.0% | Unchanged |
| Moloney Securities Asset Management, LLC | 267,500 | $302.3K | 0.04% | −27,500−9.3% | Reduced |
| Nuveen, LLC | 272,007 | $307.4K | 0.00% | +56,641+26.3% | Added |
| Man Group plc | 274,684 | $310.4K | 0.00% | +88,588+47.6% | Added |
| Alliancebernstein L.P. | 296,498 | $335.0K | 0.00% | +108,090+57.4% | Added |
| Graham Capital Management, L.P. | 302,270 | $341.6K | 0.01% | +302,270 | New |
| Susquehanna International Group, LLP | 304,812 | $344.4K | 0.00% | +147,168+93.4% | Added |
| Bank of New York Mellon Corp | 375,037 | $423.8K | 0.00% | +43,845+13.2% | Added |
| Invesco Ltd. | 396,512 | $448.1K | 0.00% | +111,305+39.0% | Added |
| Cerity Partners LLC | 400,267 | $452.3K | 0.00% | +19,843+5.2% | Added |
| Jane Street Group, LLC | 412,630 | $466.3K | 0.00% | −704,051−63.0% | Reduced |
| Raiffeisen Bank International AG | 402,000 | $498.3K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 492,121 | $556.0K | 0.04% | +8,353+1.7% | Added |
| Manufacturers Life Insurance Company, The | 494,500 | $558.8K | 0.00% | +8,634+1.8% | Added |
| Zacks Investment Management | 512,301 | $578.9K | 0.00% | −6,540−1.3% | Reduced |
| TD Asset Management Inc | 545,388 | $616.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 608,969 | $688.1K | 0.00% | −1,744,132−74.1% | Reduced |
| Citigroup Inc | 642,542 | $726.1K | 0.00% | −45,982−6.7% | Reduced |
| Barclays PLC | 645,325 | $729.2K | 0.00% | −10,066−1.5% | Reduced |
| Standard Life Aberdeen plc | 867,250 | $980.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 878,987 | $993.3K | 0.00% | +7,390+0.8% | Added |
| JPMorgan Chase & Co | 934,023 | $1.06M | 0.00% | −4,202,774−81.8% | Reduced |
| FMR LLC | 983,001 | $1.11M | 0.00% | −6,411,161−86.7% | Reduced |
| Royal Bank of Canada | 986,300 | $1.11M | 0.00% | +932,439+1,731.2% | Added |
| Bank of America Corp | 987,495 | $1.12M | 0.00% | +38,686+4.1% | Added |
| Gilead Sciences, Inc. | 1,156,689 | $1.31M | 0.10% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 1,232,535 | $1.39M | 0.00% | +76,691+6.6% | Added |
| Northern Trust Corp | 1,274,292 | $1.44M | 0.00% | +79,882+6.7% | Added |
| DAFNA Capital Management LLC | 1,380,118 | $1.56M | 0.43% | 00.0% | Unchanged |
| Millennium Management LLC | 1,502,724 | $1.70M | 0.00% | +1,245,875+485.1% | Added |
| Two Sigma Investments, LP | 1,613,225 | $1.82M | 0.00% | −461,874−22.3% | Reduced |
| Renaissance Technologies LLC | 1,670,012 | $1.89M | 0.00% | +113,312+7.3% | Added |
| Two Sigma Advisers, LP | 1,767,400 | $2.00M | 0.00% | −433,400−19.7% | Reduced |
| Vida Ventures Advisors, LLC | 1,798,163 | $2.03M | 12.76% | 00.0% | Unchanged |
| UBS Group AG | 2,038,919 | $2.30M | 0.00% | −104,191−4.9% | Reduced |
| Patient Square Capital LP | 2,635,000 | $2.98M | 1.07% | +266,814+11.3% | Added |
| State Street Corp | 2,722,742 | $3.08M | 0.00% | −67,035−2.4% | Reduced |
| Dimensional Fund Advisors LP | 2,736,419 | $3.09M | 0.00% | −443,434−13.9% | Reduced |
| Wildcat Capital Management, LLC | 2,920,787 | $3.12M | 1.85% | 00.0% | Unchanged |
| Foresite Capital Management VI LLC | 2,875,357 | $3.25M | 1.83% | −572,918−16.6% | Reduced |
| Geode Capital Management, LLC | 3,794,827 | $4.29M | 0.00% | +435,389+13.0% | Added |
| Frazier Life Sciences Management, L.P. | 3,868,750 | $4.37M | 0.17% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 4,030,872 | $4.56M | 0.00% | −175,132−4.2% | Reduced |
| Woodline Partners LP | 4,360,608 | $4.93M | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 5,503,141 | $6.22M | 0.00% | −350,833−6.0% | Reduced |
| Primecap Management Co | 5,719,140 | $6.46M | 0.01% | +787,300+16.0% | Added |
| Vanguard Group Inc | 8,259,128 | $9.33M | 0.00% | +191,575+2.4% | Added |
| Citadel Advisors LLC | 10,252,606 | $11.6M | 0.01% | +49,277+0.5% | Added |
| Darwin Global Management, Ltd. | 10,479,791 | $12.4M | 0.52% | +30,000+0.3% | Added |
| Lynx1 Capital Management LP | 11,057,009 | $12.5M | 3.61% | 00.0% | Unchanged |
| Capital World Investors | 11,150,000 | $12.6M | 0.00% | −1,115,330−9.1% | Reduced |
| BlackRock, Inc. | 17,897,400 | $20.2M | 0.00% | −35,506−0.2% | Reduced |
| TPG GP A, LLC | 18,716,306 | $21.1M | 1.13% | 00.0% | Unchanged |
| Pfizer Inc | 22,032,040 | $24.9M | 4.32% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −244,528−100.0% | Sold out |
| RMB Capital Management, LLC | 0 | $0 | 0.00% | −195,890−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −125,703−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −79,823−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −68,858−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −62,887−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −53,800−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −43,940−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −30,731−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −23,766−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −21,506−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −16,621−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −14,580−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −15,389−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −13,747−100.0% | Sold out |
| PAX Financial Group, LLC | 0 | $0 | 0.00% | −12,111−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −11,828−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −10,879−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −4,880−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −865−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −774−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −510−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −205−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Callan Capital, LLC | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |